Compare Eaton Corporation plc (ETN) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Illumina, Inc. — how do they compare? Eaton Corporation plc trades at $395.22 (market cap $160.31B), while Illumina, Inc. trades at $189.01 (market cap $28.32B). The key difference: Eaton Corporation plc is far larger — about 5.7× Illumina, Inc.'s market cap, and Eaton Corporation plc pays a 1.07% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ETN | ILMN | |
|---|---|---|
Market Cap | $160.31B | $28.32B |
Sector | Technology | Health |
52-Week High | $435.78 | $194.33 |
52-Week Low | $315.82 | $91.00 |
Enterprise Value | $181.40B | $29.70B |
Dividend Yield | 1.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $395.5, down 4.82% over 24 hours, but remains near its 52-week high. The stock shows a bullish technical trend with strong moving averages and support at $392. Fundamentally, the company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.81 exceeding the $2.73 estimate. Revenue for 2025 reached $27.45 billion, with a net income margin of 13.99%. Analyst sentiment is overwhelmingly positive, with a consensus price target of $449.50 and 64.1% of analysts rating it a Buy.
The outlook for ETN is favorable, driven by strong demand in data center power infrastructure and recent strategic acquisitions. However, risks include elevated valuation multiples like a P/E of 40.4 and potential macroeconomic pressures on industrial spending. The stock offers upside to the consensus target but requires monitoring of execution on growth initiatives and competitive dynamics in the power management sector.
Illumina (ILMN) trades at $188.27, down 1.53% on the day, yet maintains a strong technical and fundamental posture. The stock is in a bullish trend, supported by consistent earnings beats, robust profitability margins, and positive analyst sentiment. Recent news highlights strong momentum in 2026, driven by sequencing demand and new product launches, positioning the company for growth despite competitive pressures.
The outlook for ILMN is positive, with earnings growth and market leadership in genomics offering upside potential. Key risks include intensifying competition from new entrants like Roche and execution challenges in a dynamic healthcare landscape. Investor sentiment remains buoyant, but vigilance on competitive threats and margin sustainability is warranted for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
